Patients with type 2 diabetes (metformin-, insulin-, and diet-controlled; n = 32) were randomized to a 12-week walking intervention (40 min, three times/week; n = 16) or standard care (control group, n = 16). Here, INS is linked to type 2 diabetes mellitus.